|
|
|
|
Vol. 61, Issue 3, 533-545, March 2002
Department of Physiology and Pharmacology, State University of New York Health Science Center, Brooklyn, New York (T.M., K.W.); Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania (C.D.N., K.W.); Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan (K.K., T.K., I.T., K.I.)
| |
Abstract |
|---|
|
|
|---|
A large number of structurally diverse compounds act as open-channel blockers of NMDA receptors. They may share discrete or overlapping binding sites within the channel. In this study, the effects of mutations in and around the membrane-spanning and pore-forming regions of NMDA receptor subunits were studied with three blockers, MK-801, memantine, and TB-3-4, using recombinant NMDA receptors expressed in Xenopus laevis oocytes. Mutations at the critical asparagine residues in the M2 loop of NR1 and NR2B and at a tryptophan residue in M2 of NR2B reduced block by MK-801, memantine, and TB-3-4. Mutations at residues in the pre-M1, M1, M3, post-M3, and post-M4 regions had differential effects on the three blockers. Many mutations in these regions reduced block by MK-801 and TB-3-4 but had no effect on block by memantine. The differential effects on block by memantine and MK-801 are unlikely to be caused by differences in the size of these blockers. Benzyl rings in MK-801 and TB-3-4 may make hydrophobic interactions with aromatic and hydrophobic amino acid residues in the pore. Some mutations in the pre-M1 and M3 regions generated constitutively open channels, characterized by large holding currents. The effects of the various mutants are discussed in the context of models based on the known structure of the pore of the KcsA potassium channel and on previous studies dealing with solvent accessible residues in NMDA receptor subunits as determined by modification after cysteine mutagenesis.
| |
Introduction |
|---|
|
|
|---|
N-Methyl-D-aspartate
(NMDA) receptors are ligandgated ion channels that have structural
similarities with the
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and
kainate receptors (Dingledine et al., 1999
). NMDA receptors have
several characteristics that distinguish them from the other glutamate
receptors. These include the requirement for two different agonists
(glutamate and glycine) to activate the receptor, a high permeability
of the channel to Ca2+, and a voltage-dependent
block of the channel by Mg2+ (Dingledine et al.,
1999
). NMDA channels are also blocked by a large number of structurally
dissimilar organic blockers including ketamine, MK-801, memantine, and
various spider toxins and polyamine derivatives (Huettner and Bean,
1988
; Collingridge and Lester, 1989
; Chen et al., 1992
; Igarashi et
al., 1997
).
With the cloning of cDNAs encoding subunits of glutamate receptors, it
has been possible to begin to delineate the structural features that
may contribute to various binding sites and/or functional domains of
these receptors. The glutamate binding site is formed by two domains
(S1 and S2) in the amino terminus and M3-M4 loop of the NR2 subunit,
whereas homologous domains in NR1 form the glycine binding site
(Kuryatov et al., 1994
; Laube et al., 1997
; Anson et al., 1998
). The
amino-terminal domain preceding S1 seems to be a regulatory domain that
may contain binding sites for modulators and antagonists such as
spermine, protons, ifenprodil, and Zn2+ (Masuko
et al., 1999
; Low et al., 2000
; Paoletti et al., 2000
). The M2 loop
region is a critical determinant of divalent cation permeability and
Mg2+ block. In particular, asparagine residues in
this region form part of a Mg2+ binding site and
contribute to the selectivity filter of the channel (Dingledine et al.,
1999
). These asparagine residues, which are in positions analogous to
the Q/R sites that control divalent cation permeability of AMPA and
kainate channels, have also been found to influence block by organic
channel blockers such as MK-801 (Dingledine et al., 1999
). There is
little information about how other residues in the membrane-spanning
and pore-forming regions of NMDA receptors affect block by compounds
such as MK-801, memantine, and other organic channel blockers.
In this article, we have studied mutations in the M2 pore-forming loop
and in the M1, M3, and M4 membrane-spanning regions and in some
adjacent regions. We determined the effects of these mutations on block
by three structurally distinct channel blockers: MK-801, memantine, and
N1-N4-N8-tribenzyl-spermidine
(TB-3-4). MK-801 is a prototypical, high-affinity NMDA channel blocker
with a very slow onset and recovery of block (Wong et al., 1986
;
Huettner and Bean, 1988
), whereas memantine is a low-affinity blocker
with much faster rates of block and unblock (Chen et al., 1992
;
Blanpied et al., 1997
). Both molecules have quite rigid structures.
TB-3-4 is a potent and selective NMDA blocker and is a much larger and
more flexible molecule than either MK-801 or memantine (Igarashi et
al., 1997
). Our results show that block by these three compounds is
affected not only by residues in the M2 loop but also by residues
toward the extracellular ends of M1, M3, and M4. Notably, mutations in
these regions have differential effects on the different blockers.
Surprisingly, many mutants that influence block by TB-3-4 also affect
MK-801 but have no effect on block by memantine.
| |
Materials and Methods |
|---|
|
|
|---|
NMDA Clones and Site-Directed Mutagenesis.
The NR1 clone
used in these studies is the NR1A variant (Moriyoshi et al., 1991
)
which lacks the 21-amino acid insert encoded by exon-5. This clone, and
some of the NR1 mutants in the M2 and M1-M2 linker region (Sakurada et
al., 1993
) were gifts from Dr. S. Nakanishi (Institute for Immunology,
Kyoto University Faculty of Medicine, Kyoto, Japan). The rat and mouse
NR2B clones (Kutsuwada et al., 1992
; Monyer et al., 1992
) were gifts
from Drs. P. H. Seeburg (Center for Molecular Biology, University
of Heidelberg, Germany) and M. Mishina (University of Tokyo, Tokyo, Japan).
2) NR2B clone containing a
1.7-kilobase HindIII-SphI fragment of the rat NR2B clone with the mutation of interest (Williams et al., 1998Numbering of Residues.
In NR1 and NR2 subunits, amino acids
are numbered from the initiator methionine as in the original paper
reporting the sequence of NR1 (Moriyoshi et al., 1991
). This differs
from the numbering system used in some other laboratories, in which
residues are numbered from the start of the mature peptide (Kuner et
al., 1996
; Beck et al., 1999
). In the case of NR1, there is an 18 amino
acid signal peptide so, for example, residue NR1(N616) described in this study corresponds to residue NR1(N598) using the alternative numbering scheme (Kuner et al., 1996
).
Expression in Oocytes and Voltage-Clamp Recording.
The
preparation of capped cRNAs and the preparation, injection, and
maintenance of oocytes were carried out as described previously (Williams et al., 1993
). Oocytes were injected with NR1 plus NR2 cRNAs
in a ratio of 1:5 (0.1-4 ng of NR1 plus 0.5-20 ng of NR2). Macroscopic currents were recorded with a two-electrode voltage-clamp using a GeneClamp 500 amplifier (Axon Instruments, Union City, CA) as
described previously (Williams, 1993
). Electrodes were filled with 3 M
KCl and had resistances of 0.4 to 4 M
. Oocytes were continuously
superfused with a saline solution (100 mM NaCl, 2 mM KCl, 1.8 mM
BaCl2, and 10 mM HEPES, pH 7.5) that contained BaCl2 rather than CaCl2 to
minimize Ca2+-activated
Cl
currents, and in most experiments oocytes
were injected with K+-BAPTA (100 nl of 40 mM, pH
7.0-7.4) on the day of recording.
|
(1) |
150 mV to +60 or +80
mV over 3 to 4 s. Leak currents, measured in the absence of
agonist and blockers, were digitally subtracted. We chose
concentrations of blockers that gave a 50 to 80% inhibition at
70 mV
at a particular mutant. For analysis of the voltage-dependence of block
by TB-3-4 or memantine, data were analyzed using the model of Woodhull
(1973)
|
(2) |
is the
fractional recovery from block at depolarized potentials,
Kd(0) is the equilibrium dissociation constant of the antagonist at a transmembrane potential of 0 mV, z is
the charge of the antagonist,
is the fraction of the membrane electric field sensed by the blocker at its binding site within that
field, F is the Faraday constant, R is the gas constant, and T is the
absolute temperature. In the fitting procedure, the parameters
,
Kd(0) and Z
were free. The
function was included in eq. 2 because, in some cells, the glutamate
response showed a small run-down or run-up over time, and the
fractional recovery from block at depolarized potentials was often
slightly different from 1.0. The inclusion of the
variable improves
the fitting procedure, but block by TB-3-4 and memantine does not show
a voltage-independent component.
To measure Ba2+ permeability, voltage ramps were
used to determine current-voltage profiles in extracellular
Na+-saline (saline solution; composition as
above) and Ba2+-saline (64 mM
BaCl2, 2 mM KCl, 10 mM HEPES, pH 7.5) as
described previously (Williams et al., 1998| |
Results |
|---|
|
|
|---|
Screening Mutations.
We initially made a series of individual
point mutations in and around the membrane-spanning and pore-forming
loop regions of the NR1 subunit. The mutants were constructed in most
cases to alter the functional side chain, for example by neutralizing the charge (E-to-Q, D-to-N), removing an aromatic ring (W-to-L, Y-to-L)
or removing a hydroxyl group (S-to-A, T-to-A). The regions that were
studied are shown schematically in Fig.
1A. We screened each mutation by
measuring block using a single concentration of TB-3-4, memantine, and
MK-801 at NR1/NR2B receptors (Fig. 1). In these experiments, we also
studied the effects of mutations on block by 100 µM
Mg2+.
|
). In some cases, we made additional mutations at
particular positions in NR1 and/or studied mutations at equivalent
positions in the NR2B subunit. We have divided the presentation of
these results into two sections. One section deals with the M2 loop region (which has previously been studied in most detail with respect
to channel blockers), and the other section deals with M1, M3, M4, and
adjacent regions.
The M2 Loop/Pore-Forming Region.
The M2 loop of NR1 contains
an asparagine (N616) that has previously been shown to influence
divalent cation permeability and block by Mg2+,
MK-801, and other channel blockers (Dingledine et al., 1999
). An N-to-Q
mutation at this position reduced block by TB-3-4, memantine, and
MK-801. The NR2B subunit contains two asparagines (N615 and N616) at
positions equivalent to N616 and S617 in NR1, and we studied mutations
at both N residues in NR2B. In the M2 region of NR1, mutations at two
tryptophan residues (W608 and W611) had small effects on block by
memantine (Fig. 1C). We have previously found that mutations at
NR1(W608) had little or no effect on Mg2+ block,
whereas mutations at NR2B(W607), a position equivalent to NR1(W608),
had dramatic effects on Mg2+ block (Williams et
al., 1998
). In light of this, we studied the effects of NR2B(W607)
mutations on block by TB-3-4, memantine, and MK-801. Thus, the studies
of the M2 region are focused on NR1(N616), NR2B(N615), NR2B(N616), and NR2B(W607).
|
|
|
for each blocker.
However, some mutations in the M2 loop region had dramatic effects on
the current-voltage profile, with block becoming more pronounced as the
cell was hyperpolarized, but with a reversal of the slope conductance
and an apparent relief of block at very hyperpolarized potentials. An
example is shown in Fig. 4C for TB-3-4 at NR2B(W607N). This type of
profile was seen with some mutants at NR1(N616), NR2B(W607), and with
combinations of those mutants. We did not attempt to fit data from
those mutants to the Woodhull model. The relief of block at very
negative membrane potentials presumably reflects permeation of TB-3-4
and memantine through the channels in these mutant receptors. The
effects are reminiscent of the effects of some N616 and W607 mutants on
block by N1-dansyl-spermine and
Mg2+, in which the mutants increased permeation
of the blockers (Chao et al., 1997
of the blockers, the
mutants increased the Kd(0) but had
little or no effect on z
(Table 1).
|
The M1, M3, and M4 Domains.
The effects of mutations in these
regions are listed in Table 2 and are
summarized (together with the effects on mutations in the M2 region) in
Fig. 5. Mutations that produced a
3-fold change in IC50 (shaded areas on Fig. 5)
were considered to be significant. In the pre-M1 and M1 regions of NR1,
an F558L mutation had a modest effect on block by TB-3-4 and MK-801
without affecting memantine (Table 2, Fig. 5), whereas mutations at
W563 had larger effects on block by TB-3-4 and MK-801, again with no
effect on block by memantine (Fig. 6B,
top, and Table 2).
|
|
|
|
Mutations That Generate Constitutively Open Channels.
In
initial experiments in which we screened a large number of mutations in
the NR1 subunit, we found that oocytes expressing NR1/NR2B receptors
with a T-to-A or T-to-S mutation at T648 (located in M3) had very large
holding currents when voltage-clamped at
70 mV. An example is shown
in Fig. 8A. Application of glutamate and
glycine to these mutants did induce inward currents, but the currents
were often irreversible on wash-out of the agonists (data not shown),
and we did not attempt to study the effects of TB-3-4, memantine, and
MK-801 at the T648 mutants. We reasoned that the large holding currents
required to voltage-clamp cells expressing NR1(T648) mutants may be due
to the expression of constitutively open channels in receptors
containing these mutants. If this were the case, replacing
extracellular Na+ (the main charge carrier) with
the large impermeant cation
N-methyl-D-glucamine (NMDG) should
reduce the currents. We also hypothesized that extracellular Mg2+, applied in the absence of agonists, would
block these constitutively open channels, provided that the mutation
does not disrupt the Mg2+ binding site. To test
this, we studied the effects of substituting NMDG for
Na+ in the extracellular solution, and we also
studied the effects of extracellular Mg2+.
Substitution of Na+ by NMDG or the addition of
100 µM Mg2+ greatly reduced the holding
currents in cells expressing receptors containing NR1(T648) mutants but
had little effect on wild-type receptors (Fig. 8, A and C). In light of
this, we also examined the effects of NMDG and
Mg2+ at many of the other key mutations that we
had characterized and at some adjacent and nearby residues (Fig. 8C).
Only mutations at Q556, P557, T648, and L657 in NR1 produced holding
currents that were larger than wild-type and were sensitive to NMDG and Mg2+ (Fig. 8, B and C). An NR2B(N649D) mutation
had a similar effect. In all cases the increased holding current, and
consequent reduction by NMDG or Mg2+, were modest
compared with the effects seen with NR1(T648) mutants.
|
Effects of Mutations on Permeability of Ba2+.
Mutations at the N residues in the M2 loop and at NR2B(W607) have
previously been shown to affect permeability of divalent cations
including Ca2+ and Ba2+
(Williams et al., 1998
; Dingledine et al., 1999
). We carried out
experiments to determine whether the key residues identified in this
study affect permeability of Ba2+. Reversal
potentials were measured in extracellular solutions that contained
Na+ or Ba2+ as the main
charge carrier. The shift in reversal potential between Na+ and Ba2+ is an index of
the permeability of the channel to Ba2+. We used
Ba2+ rather than Ca2+ in
these studies to minimize Ca2+-activated
Cl
conductances (Leonard and Kelso, 1990
). At
wild-type NR1/NR2B receptors, the reversal potentials were
1.6 ± 0.3 mV (Na+) and +21.1 ± 0.6 mV
(Ba2+). As shown in Fig.
9, mutations at NR1(N616) and NR2B(W607)
in the M2 loop had characteristic effects on Ba2+
permeability (Dingledine et al., 1999
). For example, mutations of
NR1(N616) to Q, G, or W markedly reduced Ba2+
permeability and an N-to-R mutation had an even larger effect. Mutations of NR2B(W607) to L, N, or A, but not to Y or F, reduced Ba2+ permeability, highlighting the importance of
an aromatic ring (as found in W, Y, and F) at this position. An
NR2B(W559L) mutation had a small effect on Ba2+
permeability but two other mutations at this position had no effect.
All of the other key mutants that were studied had no effect on
Ba2+ permeability (Fig. 9). This highlights the
specificity of these mutations and indicates that these residues are
determinants of block by TB-3-4 and MK-801 but not of
Ba2+ permeability.
|
| |
Discussion |
|---|
|
|
|---|
In this study, we have identified residues in several regions of
NMDA receptor subunits that differentially affect block by MK-801,
memantine, and TB-3-4. A model that summarizes this work is shown in
Fig. 10. The model is based, in part,
on previous studies in which solvent-accessible residues were probed
with MTS reagents after cysteine substitution (Kuner et al., 1996
; Beck
et al., 1999
). The M2 segment of NR1 was proposed to contain an
-helix terminating at N616 followed by an extended structure or
random coil (Kuner et al., 1996
). The critical asparagines in the M2 loop of NR1 and NR2B form the binding sites for
Mg2+ and contribute to the narrow constriction of
the pore (Wollmuth et al., 1996
; Wollmuth et al., 1998a
,b
).
|
The model is also related to the known structure of the KcsA potassium
channel (Doyle et al., 1998
). There is some amino acid homology between
the M2 loops of glutamate receptor subunits and the pore helix of KcsA,
although in the case of NMDA receptor subunits, the homology is very
limited (Fig. 11). It is possible that
the M1 through M3 region of NMDA receptors has a structure similar to
KcsA; M1 corresponds to the outer helix and M3 to the inner helix of
KcsA. Indeed, secondary structure prediction of these regions of NR1
and NR2B suggests the presence of
helices in M1, M2, and M3 (Fig.
11). KcsA channel subunits have a pore-forming loop containing an
helix followed by a random coil; this structure may be similar to the
M2 loop region of glutamate receptor subunits (Panchenko et al., 2001
).
Notably, the secondary structure predicted for NR1 has an M2 helix that
ends just before N616, consistent with the model proposed by Kuner et
al. (1996)
. A shorter helix is predicted in the M2 region of NR2B (Fig.
11). In this context, it is notable that there is very little amino
acid identity between the M2 regions of NR1 and NR2B. It is thus
conceivable that the pore loops in NR1 and NR2B are somewhat different
in terms of their structure, length, or positioning within the pore.
Compared with KcsA, NMDA receptor subunits contain another putative
helix, M4, so the overall packing and arrangement of the membrane
spanning helices in glutamate receptor subunits may be different from
those in KcsA.
|
Mutations at the critical asparagines in M2 (N616 in NR1, N615 and N616
in NR2B) had marked effects on block by MK-801 and memantine and modest
effects on block by TB-3-4. It is likely that these residues interact
with the amino group of MK-801 and memantine and, possibly, with one of
the amino groups of TB-3-4. The effects of mutations at NR1(N616) and
NR2B(N615) were additive, suggesting that they make separate
contributions to a binding site for the blocker. Some N-site
mutations not only reduced the affinity but also increased the apparent
permeation of TB-3-4 and memantine, similar to effects on block by
N1-dansyl-spermine (Chao et al.,
1997
). Mutations such as NR1(N616G) presumably increase the size of the
narrow constriction, allowing the cationic blockers to actually
permeate the channel when the driving force is sufficiently large. The
values of z
for TB-3-4 and memantine at wild-type receptors were
1.38 and 0.89, respectively. Assuming that only one molecule of each
blocker binds within the transmembrane electrical field, this would
correspond to
values of 0.46 for TB-3-4 and 0.89 for memantine.
TB-3-4 is a long and highly flexible molecule. If it bound in the
channel in an extended conformation, then the positive charges might be
distributed over some distance and it is difficult to strictly
interpret the
values as a depth of field for this molecule. In the
case of memantine, it is possible that two molecules of memantine bind
simultaneously within the channel (Sobolevsky and Koshelev, 1998
). This
would yield an average
value of 0.45 for memantine, consistent with the tip of the helix being located about halfway across the membrane electrical field (Fig. 10).
We have shown previously that mutations at NR2B(W607) alter block and
permeation of extracellular Mg2+ (Williams et
al., 1998
). The effects of the NR2B(W607) mutants seen in the present
study were reminiscent of their effects on block and permeation of
Mg2+, with an aromatic residue at this position
being important for block by the organic blockers. Mutations at the
equivalent residue in NR1, W608, have little or no effect. We suggested
previously that NR2B(W607) may contribute directly to the narrow
constriction and Mg2+ binding site (Williams et
al., 1998
). In this case, it could also contribute to the binding site
for organic channel blockers such as MK-801, TB-3-4, and memantine
(Fig. 10). Another possibility is that NR2B(W607) forms part of a
structural backbone that is important for control of the pore
structure. There is a conserved tryptophan in an equivalent position in
KcsA (W67), the side chain of which is not exposed to the lumen of the
channel but forms part of a cuff of aromatic residues that constrain
the opening of the channel pore (Doyle et al., 1998
).
In addition to M2, the other regions in which we identified residues
that influence channel block were the pre-M1, M1, M3, post-M3, and
pre-M4 regions. In the model (Fig. 10), the channel is shown as a
structure with a pore formed by the helix and random coil in M2 and an
outer vestibule formed by the M3 and post-M3 segments. The pre-M1 and
M4 regions may also contribute to the vestibule (Beck et al., 1999
).
The helices are proposed to span a membrane distance of 34 Å with the
dimension of the narrow constriction being 5.5 Å (Villarroel et al.,
1995
; Wollmuth et al., 1996
). Thus, in this model, it is possible to
show the relative positions of residues along each helix, but the
relative positioning of residues between helices is uncertain and the
relative positions of residues that lie in random coil structures
(e.g., in the pre-M1 and post-M3 regions) is unknown. In addition to
residues that affect sensitivity to blockers, we identified several
mutations that generate constitutively open NMDA channels. The largest
effects were seen with mutations at T648 in M3, but mutations at Q556 and P557 in M1 and L657 in M3 also had effects (Fig. 10, dark blue circles). These mutants presumably affect gating of the channel. Residue T648 is near residue A653, which is equivalent to a residue in
the
2 channel (an "orphan" channel related by sequence homology to glutamate receptors) at which an A-to-T mutation generates constitutively open channels responsible for the Lurcher
mouse phenotype (Zuo et al., 1997
). A-to-T mutations at NR1(A653) or NR2B(A652) do not generate constitutively open channels (K. Williams, unpublished observations), but the effects of the T648 mutants suggest
that the M3 region in NMDA receptors is, like the equivalent region in
2, important for channel gating.
Many, but not all, of the residues identified in the current study that
influence channel blockers were previously shown to be exposed in the
channel lumen (Kuner et al., 1996
; Beck et al., 1999
). The side chains
of residues that are exposed to the lumen could interact directly with
channel blockers, forming part of their binding sites. It is possible
that residues N650, Y647, and possibly A653 in NR1, and Y646 and N649
in NR2B interact directly with MK-801 and TB-3-4 (Fig. 10). At least
some of these residues are solvent exposed and positioned at a level
such that MK-801 and TB-3-4 could interact with their side chains and
simultaneously interact with the N residues in M2. In particular,
NR1(N650) may bind to an amino group of TB-3-4 because an N-to-A
mutation reduces the affinity for TB-3-4, whereas an N-to-D mutation
increases affinity. The roles of residues at the top of M1 and M3 and
in the pre-M1 and post-M3 regions are more difficult to interpret. Mutations at residues NR1(W563) and NR2B(W559) had pronounced effects
on block by MK-801 and TB-3-4, but these residues were reported to not
be solvent exposed (Beck et al., 1999
). We found that an aromatic
residue (W, Y, or F) at these positions was important for block by
MK-801 and TB-3-4. The aromatic residue may be important for
stabilizing the channel structure and/or stabilizing a binding site
within the channel. Also, it seems unlikely that MK-801 (drawn to scale
on Fig. 10) could interact directly with residues at the top of the M1
and M3 helices while simultaneously interacting with the M2
asparagines, although a direct interaction of TB-3-4 with these
residues is conceivable.
Clearly, there are many residues that affect block by MK-801 but do not affect block by memantine (Fig. 10, green circles). Memantine and MK-801 have a similar overall size and both are influenced by the critical asparagines in M2. It is unlikely that differences in the effects of the M1, M3, and M4 mutants can be explained on the basis of the sizes of MK-801 versus memantine. However, MK-801 contains benzyl rings and is more likely to make hydrophobic interactions with aromatic residues in the pore. It is possible that some residues that influence MK-801 (but not memantine) do so by altering access of the blocker to its binding site or by allosteric disruptions of the binding site. It is also possible that some mutants that influence two or more antagonists do so indirectly or allosterically rather than by directly altering side chains (or the positioning of backbone peptide groups) within the binding site. However, the mutations at these positions do not simply have general nonspecific effects on the pore structure, evidenced by their lack of effect on block by memantine and Mg2+ and their lack of effect on Ba2+ permeability.
| |
Acknowledgment |
|---|
We are grateful to Dr. A. Shirahata for supplying TB-3-4.
| |
Footnotes |
|---|
Received July 26, 2001; Accepted December 4, 2001
1 Present address: College of Pharmacy, Nihon University, Funabashi, Japan.
Supported by Unites States Public Health Service grant NS35047 and the Hamaguchi Foundation for the Advancement of Biochemistry, Japan.
Dr. Keith Williams, Department of Physiology and Pharmacology, SUNY Health Science Center, Brooklyn, 450 Clarkson Avenue, Box 31, Brooklyn, NY 11203-2098. E-mail: keithwnyc{at}mindspring.com
| |
Abbreviations |
|---|
NMDA, N-methyl-D-aspartate;
AMPA,
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid;
TB-3-4, N1-N4-N8-tribenzyl-spermidine;
BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic
acid;
NMDG, N-methyl-D-glucamine.
| |
References |
|---|
|
|
|---|
R2) in the amino terminus of the N-methyl-D-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein.
Mol Pharmacol
55:
957-969
2 glutamate receptor gene.
Nature (Lond)
388:
769-773[CrossRef][Medline].
This article has been cited by other articles:
![]() |
T. Masuko, R. Namiki, Y. Nemoto, M. Miyake, Y. Kizawa, T. Suzuki, K. Kashiwagi, K. Igarashi, and T. Kusama Neuroprotection by Tosyl-Polyamine Derivatives through the Inhibition of Ionotropic Glutamate Receptors J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 522 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Kotermanski, J. T. Wood, and J. W. Johnson Memantine binding to a superficial site on NMDA receptors contributes to partial trapping J. Physiol., October 1, 2009; 587(19): 4589 - 4604. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Kotermanski and J. W. Johnson Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine J. Neurosci., March 4, 2009; 29(9): 2774 - 2779. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jin, M. Miyazaki, S. Mizuno, M. Takigawa, T. Hirose, K. Nishimura, T. Toida, K. Williams, K. Kashiwagi, and K. Igarashi The Pore Region of N-Methyl-D-aspartate Receptors Differentially Influences Stimulation and Block by Spermine J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 68 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Wilding, E. Fulling, Y. Zhou, and J. E. Huettner Amino Acid Substitutions in the Pore Helix of GluR6 Control Inhibition by Membrane Fatty Acids J. Gen. Physiol., July 1, 2008; 132(1): 85 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. U. Weigt, O. Adolph, M. Georgieff, E. M. Georgieff, and K. J. Fohr Evidence That Xenon Does Not Produce Open Channel Blockade of the NMDA Receptor J Neurophysiol, April 1, 2008; 99(4): 1983 - 1987. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-R. Chang and C.-C. Kuo The Activation Gate and Gating Mechanism of the NMDA Receptor J. Neurosci., February 13, 2008; 28(7): 1546 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Wrighton, E. J. Baker, P. E. Chen, and D. J. A. Wyllie Mg2+ and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes J. Physiol., January 1, 2008; 586(1): 211 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Sobolevsky, M. L. Prodromou, M. V. Yelshansky, and L. P. Wollmuth Subunit-specific Contribution of Pore-forming Domains to NMDA Receptor Channel Structure and Gating J. Gen. Physiol., June 1, 2007; 129(6): 509 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jin, H. Sugiyama, M. Takigawa, D. Katagiri, H. Tomitori, K. Nishimura, N. Kaur, O. Phanstiel IV, M. Kitajima, H. Takayama, et al. Comparative Studies of Anthraquinone- and Anthracene-Tetraamines as Blockers of N-Methyl-D-aspartate Receptors J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 47 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cui, M. Xu, and M. Atzori Voltage-Dependent Block of N-Methyl-D-aspartate Receptors by Dopamine D1 Receptor Ligands Mol. Pharmacol., November 1, 2006; 70(5): 1761 - 1770. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. V. Chen and S. A. Lipton Pharmacological Implications of Two Distinct Mechanisms of Interaction of Memantine with N-Methyl-D-aspartate-Gated Channels J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 961 - 971. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kashiwagi, I. Tanaka, M. Tamura, H. Sugiyama, T. Okawara, M. Otsuka, T. N. Sabado, K. Williams, and K. Igarashi Anthraquinone Polyamines: Novel Channel Blockers to Study N-Methyl-D-Aspartate Receptors J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 884 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Low, P. Lyuboslavsky, A. French, P. Le, K. Wyatte, W. H. Thiel, E. M. Marchan, K. Igarashi, K. Kashiwagi, K. Gernert, et al. Molecular Determinants of Proton-Sensitive N-Methyl-D-aspartate Receptor Gating Mol. Pharmacol., June 1, 2003; 63(6): 1212 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Williams, M. Dattilo, T. N. Sabado, K. Kashiwagi, and K. Igarashi. Pharmacology of delta 2 Glutamate Receptors: Effects of Pentamidine and Protons J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 740 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. DAVENPORT Glutamate Receptors in Plants Ann. Bot., November 1, 2002; 90(5): 549 - 557. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||